Skip to main content
Beijing SL Pharmaceutical Co., Ltd. logo

Beijing SL Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002038 ISIN · CNE000001L31 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,472 across all filing types
Latest filing 2017-04-27 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002038

About Beijing SL Pharmaceutical Co., Ltd.

https://www.slpharm.com.cn

Beijing SL Pharmaceutical Co., Ltd. specializes in the research, development, manufacturing, and commercialization of pharmaceutical products. The company focuses on several therapeutic areas, including cardiovascular and cerebrovascular diseases, oncology, and infectious diseases. Its product portfolio features a range of chemical drugs and active pharmaceutical ingredients (APIs), with key offerings such as clopidogrel bisulfate and amlodipine besylate. Operating with advanced production facilities that adhere to international Good Manufacturing Practice (GMP) standards, the company emphasizes technological innovation and quality control. The organization serves both domestic and international markets, leveraging its integrated R&D platform to develop generic medications and innovative formulations aimed at improving patient outcomes.

Recent filings

Filing Released Lang Actions
关于公司高管辞职的公告
Board/Management Information Classification · 100% confidence The document is a short announcement regarding the resignation of a company's senior executive (vice general manager). It includes details about the resignation, the executive's shareholding, and a statement of gratitude from the board. There are no financial statements, no mention of financial results, no regulatory certifications, or report attachments. The content clearly fits the category of announcing changes in senior management.
2017-04-27 Chinese
2016年度社会责任报告
Environmental & Social Information Classification · 95% confidence The document is titled '2016年度社会责任报告' which translates to '2016 Annual Social Responsibility Report' of Beijing SL Pharmaceutical Co., Ltd. It covers topics such as company basic information, shareholder and creditor rights protection, employee rights protection, supplier and customer rights protection, environmental protection, and sustainable development. The content focuses on the company's performance and initiatives related to Environmental, Social, and Governance (ESG) factors, including social responsibility, employee welfare, environmental compliance, and community engagement. There is no indication that this is a financial report like an Annual Report (10-K) or Interim Report (IR), nor is it an announcement or a certification. The document is a detailed report on the company's social responsibility activities and ESG performance for the year 2016. Therefore, it fits the category of Environmental & Social Information (SR). The document length (15,000 characters) and detailed content support this classification with high confidence.
2017-04-27 Chinese
独立董事魏素艳2016年度述职报告
Management Reports Classification · 95% confidence The document is a detailed 2016 annual performance report by an independent director of Beijing Shuanglu Pharmaceutical Co., Ltd. It includes the director's attendance at board meetings, opinions on profit distribution, internal control reports, audit firm appointment, related party transactions, and other governance and oversight activities during the year 2016. The content focuses on the independent director's duties, opinions, and oversight related to the company's governance and financial matters for the year 2016. This type of document is a management or director's report on their activities and opinions for the year, rather than a full annual report or audit report. It is not a simple announcement or certification but a substantive report on management and governance activities. Therefore, the best fitting category is Management Reports (MDA).
2017-04-27 Chinese
关于召开2016年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2016 Annual General Meeting (AGM) of Beijing Shuanglu Pharmaceutical Co., Ltd. It includes information about the meeting date, voting procedures, agenda items to be discussed (such as the 2016 annual report, financial statements, profit distribution plan, and appointment of auditors), and instructions for shareholders on how to participate and vote. The document does not contain the actual annual report or financial statements but rather serves as a formal notification and procedural guide for the AGM. The length is about 4591 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2017-04-27 Chinese
监事会对公司2016年内部控制评价报告的意见
Audit Report / Information Classification · 95% confidence The document is an opinion from the Supervisory Board regarding the company's 2016 internal control evaluation report. It references compliance with regulatory guidelines and internal control standards, and it provides an assessment of the internal control system's effectiveness. The document is not the internal control report itself but an opinion on it, which aligns with an Audit Report / Information type filing, as it relates to internal control evaluation and audit-related commentary rather than a full annual report or other categories. FY 2016
2017-04-27 Chinese
2017年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled '2017 年第一季度报告' which translates to '2017 First Quarter Report'. It contains detailed financial data such as revenue, net profit, cash flow, earnings per share, and asset and liability balances as of March 31, 2017. It also includes management statements ensuring the accuracy of the report, detailed shareholder information, and notes on financial metrics and changes. The length of the document is substantial (15,000 characters), and it contains actual financial statements and substantive financial data for a period shorter than a full fiscal year (quarterly). Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2017
2017-04-27 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.